Chreto chreto.com


Chreto is developing a novel, cost effective, generic and single use affinity purification technology platform for all biologicals made by the biopharmaceutical industry and plasma fractionation industry. The DAP technology will radically change the cost structure and improve the process efficiencies of downstream processing of large biomolecules.

Chreto is developing a novel, cost effective, generic and single use affinity purification technology platform for all biologicals made by the biopharmaceutical industry and plasma fractionation industry. The DAP technology will radically change the ...Show all

Company (Alive / Active)

Phone: +45 22 92 80 82

Fax:

Lejrvej 17

Vaerlose, DK-3500
Denmark

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Chreto $2.3M Aug 31, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Chreto Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Dual affinity polypeptides for purification Nov 21, 2013 Jun 28, 2016 Patent